Interestingly, the GL21.T-miR-34c-3p chimaera decreased CDK1 levels (Fig. 5d), supporting the possibility of using aptamer-based methods for targeted delivery of miR-34c-3p to NSCLC cells. The gene discussed is CDK1; the disease is non-small cell lung carcinoma.